Cargando…

Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs

Muscle wasting disease indications are among the most debilitating and often deadly noncommunicable disease states. As a comorbidity, muscle wasting is associated with different neuromuscular diseases and myopathies, cancer, heart failure, chronic pulmonary and renal diseases, peripheral neuropathie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodgers, Buel D, Ward, Christopher W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905337/ https://www.ncbi.nlm.nih.gov/pubmed/34520530 http://dx.doi.org/10.1210/endrev/bnab030

Ejemplares similares

Myostatin/Activin-A Signaling in the Vessel Wall and Vascular Calcification
por: Esposito, Pasquale, et al.
Publicado: (2021)

Inhibition of Activin/Myostatin signalling induces skeletal muscle hypertrophy but impairs mouse testicular development
por: Vaughan, Danielle, et al.
Publicado: (2020)

Compression of morbidity in a progeroid mouse model through the attenuation of myostatin/activin signalling
por: Alyodawi, Khalid, et al.
Publicado: (2019)

New function of the myostatin/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration
por: Pasteuning-Vuhman, Svitlana, et al.
Publicado: (2017)

A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities
por: Vaughan, Danielle, et al.
Publicado: (2021)

Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A
por: Lee, Se-Jin, et al.
Publicado: (2020)

Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight
por: Lee, Se-Jin, et al.
Publicado: (2020)

Activin/myostatin receptor signaling and vascular calcifications in chronic kidney disease: A “liaison dangereuse”?
por: Garibotto, Giacomo, et al.
Publicado: (2019)

The orphan ligand, activin C, signals through activin receptor-like kinase 7
por: Goebel, Erich J, et al.
Publicado: (2022)

Muscle NAD(+) depletion and Serpina3n as molecular determinants of murine cancer cachexia—the effects of blocking myostatin and activins
por: Hulmi, J.J., et al.
Publicado: (2020)

Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone
por: Iskenderian, Andrea, et al.
Publicado: (2018)

The role of myostatin in muscle wasting: an overview
por: Elkina, Yulia, et al.
Publicado: (2011)

Whole‐Body Metabolism and the Musculoskeletal Impacts of Targeting Activin A and Myostatin in Severe Osteogenesis Imperfecta
por: Omosule, Catherine L., et al.
Publicado: (2023)

Activin Receptor-Ligand Trap for the Treatment of β-thalassemia: A Serendipitous Discovery
por: Brancaleoni, Valentina, et al.
Publicado: (2020)

The salmonid myostatin gene family: a novel model for investigating mechanisms that influence duplicate gene fate
por: Lawson, Casey B, et al.
Publicado: (2012)

Activin E is a TGFβ ligand that signals specifically through activin receptor-like kinase 7
por: Vestal, Kylie A, et al.
Publicado: (2023)

Regulation of Myostatin on the Growth and Development of Skeletal Muscle
por: Chen, Ming-Ming, et al.
Publicado: (2021)

Opposite effects of Activin type 2 receptor ligands on cardiomyocyte proliferation during development and repair
por: Dogra, Deepika, et al.
Publicado: (2017)

Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver
por: Hentilä, Jaakko, et al.
Publicado: (2019)

Myostatin in the Pathophysiology of Skeletal Muscle
por: Carnac, Gilles, et al.
Publicado: (2007)

Myostatin: A Skeletal Muscle Chalone
por: Lee, Se-Jin
Publicado: (2023)

Endocranial and masticatory muscle volumes in myostatin-deficient mice
por: Jeffery, Nathan, et al.
Publicado: (2014)

Role of activin receptor-like kinase 1 in vascular development and cerebrovascular diseases
por: Hong, Jun-Mou, et al.
Publicado: (2020)

Kaempferol attenuates liver fibrosis by inhibiting activin receptor–like kinase 5
por: Xu, Taifu, et al.
Publicado: (2019)

Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting
por: Levolger, S., et al.
Publicado: (2019)

Regulation of myostatin expression is associated with growth and muscle development in commercial broiler and DMC muscle
por: Dou, Tengfei, et al.
Publicado: (2018)

Blocking myostatin: muscle mass equals muscle strength?
por: Anker, Markus S., et al.
Publicado: (2020)

Proteomic Studies on the Mechanism of Myostatin Regulating Cattle Skeletal Muscle Development
por: Sheng, Hui, et al.
Publicado: (2021)

Muscle and serum myostatin expression in type 1 diabetes
por: Dial, Athan G., et al.
Publicado: (2020)

Inhibition of activin A receptor signalling attenuates age-related pathological cardiac remodelling
por: Clavere, Nicolas G., et al.
Publicado: (2022)

Mice overexpressing growth hormone exhibit increased skeletal muscle myostatin and MuRF1 with attenuation of muscle mass
por: Consitt, Leslie A., et al.
Publicado: (2017)

Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin‐Deficient Diabetic Mice
por: Bunn, R Clay, et al.
Publicado: (2023)

Myostatin gene promoter: structure, conservation and importance as a target for muscle modulation
por: Grade, Carla Vermeulen Carvalho, et al.
Publicado: (2019)

Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues
por: Schaik, R H N van, et al.
Publicado: (2000)

Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders
por: Katagiri, Takenobu, et al.
Publicado: (2021)

The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy
por: Samant, Sadhana A., et al.
Publicado: (2017)

Plasma and Muscle Myostatin in Relation to Type 2 Diabetes
por: Brandt, Claus, et al.
Publicado: (2012)

Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps
por: Baczek, Jan, et al.
Publicado: (2020)

Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases
por: Abati, Elena, et al.
Publicado: (2022)

Molecular profiles of Quadriceps muscle in myostatin-null mice reveal PI3K and apoptotic pathways as myostatin targets
por: Chelh, Ilham, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_12k4koakcv26gmn0v84e942shq